ANIXA BIOSCIENCES, INC. Accumulated Other Comprehensive Income
ANIXA BIOSCIENCES, INC. (ANIX) had Accumulated Other Comprehensive Income of -$46.37 thousand as of 2014-07-31, per its 10-Q filed 2014-09-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2014-09-15
- 2014-07-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$46.37K.
- 2014-04-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$219.89K.
- 2014-01-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$210.91K.
- 2013-07-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.11M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2014-07-31 | -$46.37K 10-Q · filed 2014-09-15 |
| 2014-04-30 | -$219.89K 10-Q · filed 2014-06-16 |
| 2014-01-31 | -$210.91K 10-Q · filed 2014-03-17 |
| 2013-07-31 | -$1.11M 10-Q/A · filed 2013-09-20 |
| 2013-04-30 | $638.73K 10-Q/A · filed 2013-06-19 |
| 2013-01-31 | $348.53K 10-Q/A · filed 2013-03-25 |
| 2012-10-31 | -$653.68K 10-K/A · filed 2014-01-17 |
| 2012-07-31 | -$779.33K 10-Q · filed 2012-09-14 |
| 2012-04-30 | -$517.56K 10-Q · filed 2012-06-14 |
| 2012-01-31 | -$104.71K 10-Q · filed 2012-03-16 |
| 2011-07-31 | -$789.03K 10-Q/A · filed 2011-10-14 |
| 2010-10-31 | $1.41M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |